- Home
- CZWI vs ORGO Comparison
CZWI vs ORGO Comparison
Compare CZWI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZWI | ORGO |
|---|---|---|
| Founded | 1938 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 166.0M |
| IPO Year | 2006 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CZWI | ORGO |
|---|---|---|
| Price | $21.36 | $0.99 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.25 | $2.00 |
| AVG Volume (30 Days) | 32.0K | ★ 601.6K |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | 8.96 | ★ 1600.00 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $6.70 | N/A |
| Revenue Next Year | $10.98 | $37.55 |
| P/E Ratio | $42.22 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $15.30 | $1.10 |
| 52 Week High | $24.43 | $7.08 |
Technical Indicators
Market Signals| Indicator | CZWI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 18.64 |
| Support Level | $20.42 | N/A |
| Resistance Level | $21.69 | $2.69 |
| Average True Range (ATR) | 0.45 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 40.76 | 0.00 |
Price Performance
Historical ComparisonAbout CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.